drugset / Trial / NCT00245570

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)

NCT00245570

Phase 3 Completed 47 enrolled Organon and Co
RandomizedCrossoverDouble-blindPrevention

Summary

To determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in patients who have a history of worsening asthma after exercise.

Timeline

Start
2005-12
Primary completion
2006-09
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 10 mg Oral
Subject Salmeterol Other / unclassified 50 ug Inhaled